Next Generation News and Research

RSS

Evidence A.2 lineage of monkeypox is mutating

In a recent study posted to the bioRxiv* preprint server, a team of researchers from India analyzed the whole genome sequences of the monkeypox virus isolated from monkeypox patients with and without international travel histories to understand the phylogenetic relations and genomic evolution of the virus that could contribute to higher transmission rates.

21 Sep 2022

Neurocomputational model could shed light on the development of cognitive abilities

A new study introduces a new neurocomputational model of the human brain that could shed light on how the brain develops complex cognitive abilities and advance neural artificial intelligence research.

20 Sep 2022

In Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunity

In a recent study posted to the medRxiv* preprint server, researchers investigated variant-wise SARS-CoV-2 reinfection cases in Denmark.

20 Sep 2022

An improved COVID-19 vaccine shows promise against Omicron in experimental models

In a recent study published in the journal Science Translational Medicine, researchers in the United States designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on the messenger ribonucleic acid (mRNA) platform.

18 Sep 2022

U of M researchers receive grant to map senescent cells in preclinical studies and human tissues

Researchers at the University of Minnesota Medical School and the Institute on the Biology of Aging and Metabolism were awarded a total of $19.3 million in grants from the National Institutes of Health Common Fund to map senescent cells in preclinical studies and human tissues as part of the SenNet Consortium.

16 Sep 2022

First Hand Experience in the Field of Clinical and Applied Mass Spectrometry

This Interview focuses on describing the Clinical and Applied Mass Spectrometry Program available at LOYOLA UNIVERSITY CHICAGO

From Loyola University Chicago Health Sciences Campus 16 Sep 2022

Winners of the 2022 CURE-19 Research Pilot Grants announced

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have announced the 2022 awardees of the CURE-19 Research Pilot Grants, an initiative to support collaborative, interdisciplinary COVID-19 research that will address both the pandemic and root causes of health disparities in New York City.

14 Sep 2022

Neisseria species are linked to worsening bronchiectasis in patients, study shows

A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered that Neisseria - a genus of bacteria that lives in the human body - is not as harmless as previously thought, and can cause infections in patients with bronchiectasis, asthma, and chronic obstructive pulmonary disease (COPD).

14 Sep 2022

Scientists identify two distinct subtypes of obesity

A team led by Van Andel Institute scientists has identified two distinct types of obesity with physiological and molecular differences that may have lifelong consequences for health, disease and response to medication.

14 Sep 2022

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

Researchers at University of California San Diego School of Medicine have been selected to lead components of the National Institutes of Health (NIH) Common Fund's Bridge to Artificial Intelligence (Bridge2AI) program.

13 Sep 2022

NIH's Bridge2AI program aims to expand use of AI by biomedical and behavioral research communities

The National Institutes of Health will invest $130 million over four years, pending the availability of funds, to accelerate the widespread use of artificial intelligence (AI) by the biomedical and behavioral research communities.

13 Sep 2022

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

A new press release announced the results of their interventional PATHFINDER study on the early detection of cancer using multi-cancer early detection (MCED) blood tests.

13 Sep 2022

Mucosal vaccination triggers superior T cell response against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* server, researchers in Singapore and the United States demonstrated that intranasal (I.N.) delivery of a mucosal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination triggered a superior T cell response compared to an equivalent dose of antigen delivered by the subcutaneous (S.C.) route.

12 Sep 2022

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

In a recent study posted to the bioRxiv* server, researchers in the United States demonstrated the efficacy of a novel biopolymer, N-dihydrogalactochitosan (GC), as an adjuvant for next-generation mucosal coronavirus disease 2019 (COVID-19) vaccine.

12 Sep 2022

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

For the first time, neuroscientists from Charité – Universitätsmedizin Berlin and the Max Planck Institute for Biological Intelligence (currently in the process of being established) have revealed the precise connections between sensory neurons inside the retina and the superior colliculus, a structure in the midbrain.

12 Sep 2022

Research could lead to a new therapeutic option for patients with bladder cancer

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.

12 Sep 2022

Study reveals two distinct types of obesity with physiological and molecular differences

12 Sep 2022

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

9 Sep 2022

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Researchers explored probable humoral immune mechanisms related to EBV curtailment, besides neutralization, by a systematic emphasis on antibody fragment crystallizable-functional activities over the course of EBV infections.

9 Sep 2022

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

MolGen B.V. of Veenendaal (NL), participates in the 24th Annual Conference of the European Society for Clinical Virology (ESCV) held in Manchester, United Kingdom on 7-10 September 2022.

From AgriGenX 9 Sep 2022

Next Generation News and Research

Evidence A.2 lineage of monkeypox is mutating

Neurocomputational model could shed light on the development of cognitive abilities

In Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunity

An improved COVID-19 vaccine shows promise against Omicron in experimental models

U of M researchers receive grant to map senescent cells in preclinical studies and human tissues

First Hand Experience in the Field of Clinical and Applied Mass Spectrometry

Winners of the 2022 CURE-19 Research Pilot Grants announced

Neisseria species are linked to worsening bronchiectasis in patients, study shows

Scientists identify two distinct subtypes of obesity

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

NIH's Bridge2AI program aims to expand use of AI by biomedical and behavioral research communities

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

Mucosal vaccination triggers superior T cell response against SARS-CoV-2 variants

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

Research could lead to a new therapeutic option for patients with bladder cancer

Study reveals two distinct types of obesity with physiological and molecular differences

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News